Search Results

There are 54928 results for: content related to: Topical therapy for oropharyngeal symptoms of myasthenia gravis

  1. You have free access to this content
    Pyridostigmine but not 3,4-diaminopyridine exacerbates ACh receptor loss and myasthenia induced in mice by muscle-specific kinase autoantibody

    The Journal of Physiology

    Volume 591, Issue 10, May 2013, Pages: 2747–2762, Marco Morsch, Stephen W. Reddel, Nazanin Ghazanfari, Klaus V. Toyka and William D. Phillips

    Article first published online : 25 MAR 2013, DOI: 10.1113/jphysiol.2013.251827

  2. Effects of subacute pyridostigmine administration on mammalian skeletal muscle function

    Journal of Applied Toxicology

    Volume 12, Issue 1, February 1992, Pages: 25–33, Michael Adler, Sharad S. Deshpande, Robert E. Foster, Donald M. Maxwell and Edson X. Albuquerque

    Article first published online : 11 JAN 2006, DOI: 10.1002/jat.2550120107

  3. The efficacy of treatment of patients with severe constipation or recurrent pseudo-obstruction with pyridostigmine

    Colorectal Disease

    Volume 12, Issue 6, June 2010, Pages: 540–548, C. J. O’Dea, S. J. H. Brookes and D. A. Wattchow

    Article first published online : 27 MAR 2009, DOI: 10.1111/j.1463-1318.2009.01838.x

  4. Interactive and delayed effects of pyridostigmine and physical stress on biochemical and histological changes in peripheral tissues of mice

    Journal of Applied Toxicology

    Volume 20, Issue 4, July/August 2000, Pages: 327–334, S. M. Somani, K. Husain, T. Asha and R. Helfert

    Article first published online : 10 AUG 2000, DOI: 10.1002/1099-1263(200007/08)20:4<327::AID-JAT697>3.0.CO;2-J

  5. Pyridostigmine in the Treatment of Postural Orthostatic Tachycardia: A Single-Center Experience

    Pacing and Clinical Electrophysiology

    Volume 34, Issue 6, June 2011, Pages: 750–755, KHALIL KANJWAL, BEVERLY KARABIN, MUJEEB SHEIKH, LAWRENCE ELMER, YOUSUF KANJWAL, BILAL SAEED and BLAIR P. GRUBB

    Article first published online : 16 MAR 2011, DOI: 10.1111/j.1540-8159.2011.03047.x

  6. Cholinergic stimulation with pyridostigmine improves autonomic function in infarcted rats

    Clinical and Experimental Pharmacology and Physiology

    Volume 40, Issue 9, September 2013, Pages: 610–616, Raquel N de La Fuente, Bruno Rodrigues, Ivana C Moraes-Silva, Leandro E Souza, Raquel Sirvente, Cristiano Mostarda, Kátia De Angelis, Pedro P Soares, Silvia Lacchini, Fernanda Consolim-Colombo and Maria-Cláudia Irigoyen

    Article first published online : 23 AUG 2013, DOI: 10.1111/1440-1681.12121

  7. A national epidemiological study of Myasthenia Gravis in Australia

    European Journal of Neurology

    Volume 19, Issue 11, November 2012, Pages: 1413–1420, M. Gattellari, C. Goumas and J. M. Worthington

    Article first published online : 2 APR 2012, DOI: 10.1111/j.1468-1331.2012.03698.x

  8. Normal myelination of regenerating peripheral nerve sprouts despite circulating antibodies to galactocerebroside in rabbits

    Annals of Neurology

    Volume 19, Issue 2, February 1986, Pages: 189–192, Guido Stoll, Karlheinz Reiners, Günther Schwendemann, Kurt Heininger and Dr Klaus V. Toyka

    Article first published online : 8 OCT 2004, DOI: 10.1002/ana.410190213

  9. EXCRETION AND METABOLISM OF [14C]-PYRIDOSTIGMINE IN THE RAT

    British Journal of Pharmacology and Chemotherapy

    Volume 26, Issue 2, February 1966, Pages: 393–402, R. D. N. BIRTLEY, J. B. ROBERTS, B. H. THOMAS and A. WILSON

    Article first published online : 19 JUL 2012, DOI: 10.1111/j.1476-5381.1966.tb01919.x

  10. Retrospective population pharmacokinetic/pharmacodynamic analysis of pyridostigmine, a cholinesterase inhibitor, in Chinese males

    Journal of Pharmacy and Pharmacology

    Volume 61, Issue 9, September 2009, Pages: 1187–1196, Kok-Yong Seng, Weng-Keong Loke, Shabbir Moochhala, Bin Zhao and Jon-Deoon Edmund Lee

    Article first published online : 8 JAN 2010, DOI: 10.1211/jpp.61.09.0008

  11. You have free access to this content
    Myasthenia gravis epidemiology in a national cohort; combining multiple disease registries

    Acta Neurologica Scandinavica

    Volume 129, Issue s198, April 2014, Pages: 26–31, J. B. Andersen, A. T. Heldal, A. Engeland and N. E. Gilhus

    Article first published online : 4 MAR 2014, DOI: 10.1111/ane.12233

  12. Effectiveness of pyridostigmine in reversing neuromuscular blockade produced by soman

    Journal of Pharmacy and Pharmacology

    Volume 30, Issue 1, September 1978, Pages: 419–425, P. DIRNHUBER and D. M. GREEN

    Article first published online : 12 APR 2011, DOI: 10.1111/j.2042-7158.1978.tb13278.x

  13. Treatment of Pyridostigmine-Induced AV Block with Hyoscyamine in a Patient with Myasthenia Gravis

    Journal of Cardiovascular Electrophysiology

    Volume 19, Issue 2, February 2008, Pages: 214–216, ANIL GEHI, MICHAEL BENATAR and JONATHAN LANGBERG

    Article first published online : 16 AUG 2007, DOI: 10.1111/j.1540-8167.2007.00938.x

  14. You have free access to this content
    THE PHARMACOKINETICS OF PYRIDOSTIGMINE AND 3-HYDROXY-N-METHYLPYRIDINIUM IN THE RAT: DOSE-DEPENDENT EFFECTS AFTER PORTAL VEIN ADMINISTRATION

    British Journal of Pharmacology

    Volume 55, Issue 3, November 1975, Pages: 335–341, H.E. BARBER, G.R. BOURNE, T.N. CALVEY and K.T. MUIR

    Article first published online : 19 JUL 2012, DOI: 10.1111/j.1476-5381.1975.tb06936.x

  15. You have free access to this content
    PLASMA CLEARANCE OF NEOSTIGMINE AND PYRIDOSTIGMINE IN THE DOG

    British Journal of Pharmacology

    Volume 63, Issue 3, July 1978, Pages: 509–512, P.R. BAKER, T.N. CALVEY, K. CHAN, C.M. MACNEE and K. TAYLOR

    Article first published online : 19 JUL 2012, DOI: 10.1111/j.1476-5381.1978.tb07805.x

  16. Pretreatment for Nerve Agent Poisoning

    Chemical Warfare Agents: Toxicology and Treatment, Second Edition

    Timothy C. Marrs, Robert L. Maynard, Frederick R. Sidell, Pages: 343–353, 2007

    Published Online : 2 APR 2007, DOI: 10.1002/9780470060032.ch17

  17. Interaction of pyridostigmine and physical stress on antioxidant defense system in skeletal muscle of mice

    Journal of Applied Toxicology

    Volume 21, Issue 4, July/August 2001, Pages: 341–348, R. Jagannathan, K. Husain and S. M. Somani

    Article first published online : 26 JUL 2001, DOI: 10.1002/jat.765

  18. Population Pharmacokinetics and Pharmacodynamics of Pyridostigmine Bromide for Prophylaxis against Nerve Agents in Humans

    The Journal of Clinical Pharmacology

    Volume 38, Issue 3, March 1998, Pages: 227–235, Dr. Mark T. Marino, Dr. Brian G. Schuster, Dr. Ralf P. Brueckner, Dr. Emil Lin, Mr. Andris Kaminskis and Dr. Kenneth C. Lasseter

    Article first published online : 8 MAR 2013, DOI: 10.1002/j.1552-4604.1998.tb04420.x

  19. You have free access to this content
    Pyridostigmine, an Acetylcholinesterase Inhibitor, Stimulates Growth Hormone Release, but has no Effect on Basal Thyrotrophin or Adrenocorticotrophin Levels, or the Thyrotrophin Response to Thyrotrophin-Releasing Hormone

    Journal of Neuroendocrinology

    Volume 2, Issue 4, August 1990, Pages: 429–432, Emma Freeman, Rick Touzel, Ashley Grossman, Michael Besser and Richard Ross

    Article first published online : 29 SEP 2006, DOI: 10.1111/j.1365-2826.1990.tb00428.x

  20. Design of the Efficacy of Prednisone in the Treatment of Ocular Myasthenia (EPITOME) trial

    Annals of the New York Academy of Sciences

    Volume 1275, Issue 1, December 2012, Pages: 17–22, Michael Benatar, Donald B. Sanders, Gil I. Wolfe, Michael P. McDermott and Rabi Tawil

    Article first published online : 20 DEC 2012, DOI: 10.1111/j.1749-6632.2012.06780.x